The US Blood Products Advisory Committee discussed product recall and concluded it should be decided on a case-by-case basis. Linked evidence BAYP0004674 - Minutes of Blood Products Advisory Committee - 19 Jul 1983 Chronology Information Date: 19 July 1983 Chapter/issue Pharmaceutical Companies